Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

In connection with the Up-C Collapse, the Rocket Companies (RKT)’ board of directors earlier today authorized and declared a cash dividend of ...

UK companies not widely covered may potentially offer a unique opportunity to buy shares in a future market winner.

Rocket Lab (NASDAQ:RKLB) stock has tumbled after it provided Q4 results. It was mostly the outlook for Q1 that disappointed investors. In one of my previous pieces, I already pointed out that the ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00. The ...

On Tuesday, Stifel, a financial services firm, adjusted its outlook on Rocket Lab USA (NASDAQ:RKLB), reducing the company's stock price target from $10.00 to $9.00, while still... Mynaric (MYNA ...

Weapons and fighter jet manufacturer BAE Systems has seen its shares soar higher as the defence sector received a boost following the Ukraine summit hosted by Prime Minister Sir Keir Starmer over the ...

Rocket Lab USA, Inc. (RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with EPS of ($0.06) coming in worse than the consensus... Rocket Lab USA, ...

The stock dropped sharply by double digits in Friday's premarket but recovered most of its losses after the opening bell. CEO Peter Beck extended the timeline for Neutron’s debut by several months but ...

LONG BEACH, Calif. - Rocket Lab USA, Inc. (NASDAQ: RKLB), a provider of launch services and space systems, has scheduled its 61st Electron rocket launch for March ...

Rocket Companies (NYSE:RKT) stock jumped 8.0% in Thursday after-hours trading after the lender's Q4 top and bottom lines exceeded Wall Street expectations as its mortgage origination volume rose ...